脓毒症中的肠-肝轴:交互机制与治疗潜力
脓毒症是机体对感染免疫反应失调所致的潜在致命性疾病,脓毒症诱导的肝损伤被视为重症监护病房死亡的强独立预后因素,且有解剖学及不断累积的流行病学证据表明肠道与肝脏之间存在密切交互。脓毒症期间肠屏障破坏与肠道菌群失调导致肠道病原相关分子模式和损伤相关分子模式易位进入肝脏和体循环。肝脏通过细菌清除、脂多糖解毒、细胞因子和急性期蛋白释放以及炎症代谢调节等机制在全身感染时对免疫防御至关重要。当肝脏发生不适当免疫反应或过度炎症时,病原清除能力受损和肝脏代谢紊乱可进一步损害肠屏障并加剧肠道菌群组成和多样性的破坏,因此肠肝交互是潜在治疗靶点。
要点
- 脓毒症诱导的肝损伤被视为重症监护病房死亡的强独立预后因素。
- 脓毒症时肠屏障破坏与肠道菌群失调导致肠道病原相关分子模式和损伤相关分子模式易位进入肝脏和体循环。
- 肝脏通过细菌清除、脂多糖解毒、细胞因子和急性期蛋白释放以及炎症代谢调节等机制调节全身感染时的免疫防御。
- 肝脏不适当免疫反应或过度炎症所致病原清除受损和代谢紊乱可进一步损害肠屏障、加剧菌群组成和多样性破坏。
- 肠肝交互是脓毒症的潜在治疗靶点。
适用人群与场景
- 脓毒症患者,尤其是发生脓毒症诱导肝损伤的重症监护病房患者。
研究设计与关键结果
- 本综述概述了脓毒症中肠道与肝脏之间密切的交互(肠-肝轴)。
- 脓毒症诱导的肝损伤被视为重症监护病房死亡的强独立预后因素,并有解剖学及不断累积的流行病学证据表明肠道与肝脏之间存在密切交互。
- 脓毒症时肠屏障破坏和肠道菌群失调导致肠道病原相关分子模式和损伤相关分子模式易位进入肝脏和体循环。
- 肝脏通过细菌清除、脂多糖解毒、细胞因子和急性期蛋白释放以及炎症代谢调节等机制调节全身感染时的免疫防御。
- 肝脏发生不适当免疫反应或过度炎症时,病原清除能力受损和肝脏代谢紊乱可进一步损害肠屏障并加剧肠道菌群组成和多样性的破坏。
- 肠肝交互是脓毒症的潜在治疗靶点。
证据类型、等级与局限
- 证据类型:综述。
- 局限:原文未报告局限性。
对床旁实践的改变
- 原文未据此给出推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
Sepsis is a potentially fatal condition caused by dysregulation of the body's immune response to an infection. Sepsis-induced liver injury is considered a strong independent prognosticator of death in the critical care unit, and there is anatomic and accumulating epidemiologic evidence that demonstrates intimate cross talk between the gut and the liver. Intestinal barrier disruption and gut microbiota dysbiosis during sepsis result in translocation of intestinal pathogen-associated molecular patterns and damage-associated molecular patterns into the liver and systemic circulation. The liver is essential for regulating immune defense during systemic infections via mechanisms such as bacterial clearance, lipopolysaccharide detoxification, cytokine and acute-phase protein release, and inflammation metabolic regulation. When an inappropriate immune response or overwhelming inflammation occurs in the liver, the impaired capacity for pathogen clearance and hepatic metabolic disturbance can result in further impairment of the intestinal barrier and increased disruption of the composition and diversity of the gut microbiota. Therefore, interaction between the gut and liver is a potential therapeutic target. This review outlines the intimate gut-liver cross talk (gut-liver axis) in sepsis.
参考来源
- Zhang X, Liu H, Hashimoto K, et al. The gut-liver axis in sepsis: interaction mechanisms and therapeutic potential. Crit Care. 2022. PMID: 35831877. doi:10.1186/s13054-022-04090-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。